Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 6/20 | 0.59 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.53 |
| ▸ | CACNA1H | O95180 | 3/20 | 0.51 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27195708 | 0.92 | CACNA1H (0.51) | TRPV1ROCK1CACNA1HCACNA1BSMN1; SMN2 | |
| SCHEMBL27195722 | 0.87 | CACNA1H (0.53) | TRPV1CACNA1HCACNA1BALDH1A1SMN1; SMN2 | |
| SCHEMBL30863554 | 0.85 | KMT2A (0.49) | TRPV1CACNA1HCACNA1BSMN1; SMN2MAPT | |
| SCHEMBL27195725 | 0.85 | KMT2A (0.49) | TRPV1CACNA1HCACNA1BSMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL30863526 | 0.84 | KMT2A (0.48) | TRPV1CACNA1HCACNA1BSMN1; SMN2MAPT | |
| SCHEMBL27195732 | 0.82 | CACNA1H (0.48) | CACNA1HCACNA1BALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL27195800 | 0.82 | CACNA1H (0.48) | CACNA1HCACNA1BALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL30863471 | 0.82 | CACNA1H (0.48) | CACNA1HCACNA1BALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL30863545 | 0.82 | TRPV1 (0.48) | TRPV1ROCK1ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL27195714 | 0.82 | TRPV1 (0.48) | TRPV1ROCK1ALDH1A1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | claimed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | claimed |
| EP-4353712-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2024-04-17 | — | — | EP | claimed |
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | disclosed |
| EP-4353712-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2024-04-17 | — | — | EP | disclosed |